ArticleFrontiers in immunology2025

Engineered sequestrins inhibit aggregation of pathogenic alpha-synuclein mutants.

Linnea Charlotta Hjelm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.